Ryan Allway September 30th, 2021 TEL AVIV, Israel and BETHESDA, Md., Sept. 30, 2021 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine and a pioneer in the development of psychedelic inspired medicine, announced today that it has updated its... Read more
Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update
Biotechnology August 26, 2021
Ryan Allway August 26th, 2021 PETACH TIKVA, Israel, August 26, 2021–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended June 30, 2021. Corporate... Read more
Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers
July 28, 2021
Ryan Allway July 28th, 2021 Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options Positions Cepharanthine’s ‘pipeline in a pill’ strategy focusing on esophageal, colorectal, liver and skin cancers Advance to FDA IND-enabling studies to support human clinical studies Toronto, Ontario–(Newsfile Corp. – July 28, 2021) –... Read more
